Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME)
NCT05206487
Summary
TIPS is a standard for the treatment of portal hypertension related complications. However, it remains at risk of HE after TIPS (around 40% the first year). Dysbiosis plays a key role in pathophysiology of HE. Polydextrose (PDX) is consider as a prebiotic. Preliminary studies showed that PDX: 1. modified gut microbiota, enhancing "good bacteria" 2. improved gut permeability and immunity in 2 experimental models: infarction and colitis. The aim of this study is to assess PDX efficacy to prevent HE during the first 6 months after TIPS in cirrhotic patients.
Eligibility
Inclusion Criteria: * Male or female at least 18 years of age * Affected (c) cirrhosis in which the establishment of a TIPS is scheduled within the month for: the treatment of ascites or a refractory hydrothorax or the prevention of the recurrence of a related digestive hemorrhage portal hypertension * Having signed the consent to participate in the study * Women of childbearing age on effective contraception * Affiliated to a social security scheme Exclusion Criteria: * Contraindication for TIPS * Digestive short circuit, chronic inflammatory bowel diseases * Indications of TIPS in emergency or as part of the preparation for a surgical procedure, * Liver transplant, * Patient for whom the follow-up is considered impossible due to non-compliance with care or because the vital prognosis is estimated less than 6 months because of an incurable chronic pathology, * Pregnant or lactating women, * Those unable to receive enlightened information, * Those participating in another interventional research including an exclusion period * Persons placed under safeguard of justice, tutelage or curators.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05206487